News

ICU Medical, Inc. Announces Time of First Quarter 2022 Earnings Conference Call

SAN CLEMENTE, Calif., April 20, 2022 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and…

2 years ago

Vericel to Report First-Quarter 2022 Financial Results on May 4, 2022

CAMBRIDGE, Mass., April 20, 2022 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine…

2 years ago

Todos Medical Reports 2nd Long COVID Case Study and Launches Website for Physicians and Pediatricians to Indicate Interest in Participating in Tollovid Long COVID Clinical Study

New York, NY, and Tel Aviv, ISRAEL, April 20, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a…

2 years ago

Certara to Report First Quarter 2022 Financial Results on May 5th, 2022

PRINCETON, N.J., April 20, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that…

2 years ago

Eyenovia CEO, CMO and Chairman Dr. Sean Ianchulev to Present at Eyecelerator @ American Society of Cataract and Refractive Surgery (ASCRS) 2022

Presentation to review historic issues related to glaucoma therapies and how these may be addressed through the use of Optejet®…

2 years ago

Ultragenyx Announces First Patient Dosed in Pivotal Phase 2/3 Clinical Study of Setrusumab (UX143) for the Treatment of Osteogenesis Imperfecta

Global study will evaluate UX143 in pediatric and young adult patients ages 5 to NOVATO, Calif., April 20, 2022 (GLOBE…

2 years ago

Healthcare Triangle Achieves HITRUST Risk-based, 2-year Certification to Manage Risk, Improve Security Posture, and Meet Compliance Requirements

HITRUST Risk-based, 2-year Certification validates Healthcare Triangle is committed to meeting key regulations and protecting sensitive informationPLEASANTON, Calif., April 20,…

2 years ago

MIMEDX to Host First Quarter 2022 Operating and Financial Results Conference Call on May 4

MARIETTA, Ga., April 20, 2022 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), a transformational placental…

2 years ago

Acarix publishes the annual report for 2021

Press release Malmö, Sweden, April 20, 2022   Acarix publishes the annual report for 2021 Today, Wednesday April 20, Acarix is publishing…

2 years ago

Jounce Therapeutics to Participate in Raymond James LILRB/ILT Symposium: Deep Dive into “Myeloid Checkpoint” Therapeutics in Cancer

CAMBRIDGE, Mass., April 20, 2022 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage company focused on the discovery…

2 years ago
Show more Posts
Show previous Posts